{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:18:17Z","timestamp":1783383497851,"version":"3.54.6"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK118200"],"award-info":[{"award-number":["K23DK118200"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R03DK129558"],"award-info":[{"award-number":["R03DK129558"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK123704"],"award-info":[{"award-number":["P30DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001450"],"award-info":[{"award-number":["UL1 TR001450"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09659-4","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:57:35Z","timestamp":1751889455000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD) at Risk for Advanced Fibrosis in a Real-World Primary Care Setting: A Cross-Sectional Study"],"prefix":"10.1007","volume":"41","author":[{"given":"Andrew D.","family":"Schreiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bolus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Bays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Mauldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulugeta","family":"Gebregziabher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"9659_CR1","doi-asserted-by":"publisher","unstructured":"Lazarus JV, Mark HE, Anstee QM, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1038\/s41575-021-00523-4.","DOI":"10.1038\/s41575-021-00523-4"},{"key":"9659_CR2","doi-asserted-by":"crossref","unstructured":"Kanwal F, Shubrook JH, Younossi Z, et al. Preparing for the NASH Epidemic: A Call to Action. Diabetes care. 2021;","DOI":"10.2337\/figshare.14932179.v1"},{"key":"9659_CR3","unstructured":"Metabolic Dysfunction\u2013Associated Steatotic Liver Disease. Annals of Internal Medicine.0(0):null."},{"key":"9659_CR4","doi-asserted-by":"crossref","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md). 2023;77(5):1797\u20131835","DOI":"10.1097\/HEP.0000000000000323"},{"issue":"5","key":"9659_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D et al (2022) American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 28(5):528\u2013562 (PubMed PMID: 35569886)","journal-title":"Endocr Pract."},{"issue":"6","key":"9659_CR6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstrom","year":"2017","unstructured":"Hagstrom H, Nasr P, Ekstedt M et al (2017) Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 67(6):1265\u20131273 (PubMed PMID: 28803953)","journal-title":"J Hepatol."},{"issue":"17","key":"9659_CR7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J et al (2021) Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease. N Engl J Med. 385(17):1559\u20131569 (PubMed PMID: 34670043; PMCID: PMC8881985)","journal-title":"N Engl J Med."},{"key":"9659_CR8","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology (Baltimore, Md). 2007;46(1):32\u201336","DOI":"10.1002\/hep.21669"},{"key":"9659_CR9","doi-asserted-by":"publisher","unstructured":"Sterling RK, Patel K, Duarte-Rojo A, et al. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology (Baltimore, Md). 9900:  https:\/\/doi.org\/10.1097\/HEP.0000000000000845.","DOI":"10.1097\/HEP.0000000000000845"},{"key":"9659_CR10","doi-asserted-by":"publisher","unstructured":"Schreiner AD, Zhang J, Durkalski-Mauldin V, et al. Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Diabetes Metab Res Rev.\u00a02021 Nov;37(8):e3452.\u00a0https:\/\/doi.org\/10.1002\/dmrr.3452.","DOI":"10.1002\/dmrr.3452"},{"key":"9659_CR11","doi-asserted-by":"crossref","unstructured":"Loomba R, Wong R, Fraysse J, et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020; 32372515.","DOI":"10.1111\/apt.15679"},{"issue":"5","key":"9659_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA et al (2021) Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 161(5):1657\u20131669 (PubMed PMID: 34602251)","journal-title":"Gastroenterology."},{"key":"9659_CR13","doi-asserted-by":"publisher","unstructured":"Nielsen EM, Anderson KP, Marsden J, Zhang J, Schreiner AD. Nonalcoholic fatty liver disease underdiagnosis in primary care: What are we missing? J Gen Intern Med. 2021.  https:\/\/doi.org\/10.1007\/s11606-021-07197-3.","DOI":"10.1007\/s11606-021-07197-3"},{"issue":"1","key":"9659_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md). 67(1):328\u2013357 (PubMed PMID: 28714183)","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"6","key":"9659_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 79(6):1542\u20131556 (PubMed PMID: 37364790)","journal-title":"J Hepatol."},{"key":"9659_CR16","doi-asserted-by":"publisher","unstructured":"World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191-2194.  https:\/\/doi.org\/10.1001\/jama.2013.281053.","DOI":"10.1001\/jama.2013.281053"},{"issue":"11","key":"9659_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.eprac.2024.08.002","volume":"30","author":"AD Schreiner","year":"2024","unstructured":"Schreiner AD, Zhang J, Moran WP et al (2024) Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Endocr Pract. 30(11):1015\u20131022 (PubMed PMID: 39127111; PMCID: PMC11532012)","journal-title":"Endocr Pract."},{"key":"9659_CR18","doi-asserted-by":"crossref","unstructured":"Schreiner AD, Zhang J, Petz CA et al (2024) Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD. BMJ Open Gastroenterol. 11(1) (PubMed PMID: 39019623; PMCID: PMC11256061)","DOI":"10.1136\/bmjgast-2024-001404"},{"key":"9659_CR19","doi-asserted-by":"crossref","unstructured":"Hagstr\u00f6m H, Adams LA, Allen AM, et al. Administrative coding in electronic health care record-based research of NAFLD: An expert panel consensus statement. Hepatology (Baltimore, Md). 2021;74(1):474\u2013482","DOI":"10.1002\/hep.31726"},{"issue":"10","key":"9659_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.cgh.2018.01.042","volume":"16","author":"S Mapakshi","year":"2018","unstructured":"Mapakshi S, Kramer JR, Richardson P, El-Serag HB, Kanwal F (2018) Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association. 16(10):1677\u20131678 (PubMed PMID: 29410051)","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association."},{"issue":"5","key":"9659_CR21","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182688d2f","volume":"47","author":"MS Nehra","year":"2013","unstructured":"Nehra MS, Ma Y, Clark C, Amarasingham R, Rockey DC, Singal AG (2013) Use of administrative claims data for identifying patients with cirrhosis. Journal of clinical gastroenterology. 47(5):e50-54 (PubMed PMID: 23090041; PMCID: PMC3556340)","journal-title":"Journal of clinical gastroenterology."},{"issue":"5","key":"9659_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF et al (2017) Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. Am J Gastroenterol. 112(5):740\u2013751 (PubMed PMID: 27725647; PMCID: PMC5418560)","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"9659_CR23","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","volume":"43","author":"H Quan","year":"2008","unstructured":"Quan H, Li B, Saunders LD et al (2008) Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 43(4):1424\u20131441 (PubMed PMID: 18756617; PMCID: PMC2517283)","journal-title":"Health Serv Res."},{"issue":"11","key":"9659_CR24","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 43(11):1130\u20131139 (PubMed PMID: 16224307)","journal-title":"Med Care."},{"key":"9659_CR25","doi-asserted-by":"publisher","unstructured":"Lilford RJ, Bentham L, Girling A, et al. Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study. Health Technol Assess (Winchester, England). 2013;17(28):i-xiv 1\u2013307. https:\/\/doi.org\/10.3310\/hta17280.","DOI":"10.3310\/hta17280"},{"issue":"4","key":"9659_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 71(4):793\u2013801 (PubMed PMID: 31279902)","journal-title":"J Hepatol."},{"issue":"2","key":"9659_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco R, Godinez Leiva E, Bril F et al (2021) Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes care. 44(2):399\u2013406 (PubMed PMID: 33355256; PMCID: PMC7818321)","journal-title":"Diabetes care."},{"issue":"3","key":"9659_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","volume":"78","author":"V Ajmera","year":"2023","unstructured":"Ajmera V, Cepin S, Tesfai K et al (2023) A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 78(3):471\u2013478 (PubMed PMID: 36410554; PMCID: PMC9975077)","journal-title":"J Hepatol."},{"issue":"3","key":"9659_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2337\/ds17-0085","volume":"31","author":"P Passarella","year":"2018","unstructured":"Passarella P, Kiseleva TA, Valeeva FV, Gosmanov AR (2018) Hypertension Management in Diabetes: 2018 Update. Diabetes Spectrum. 31(3):218\u2013224","journal-title":"Diabetes Spectrum."},{"issue":"1","key":"9659_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2337\/cd22-as01","volume":"40","author":"AD Association","year":"2022","unstructured":"Association AD (2022) Standards of Medical Care in Diabetes\u20142022 Abridged for Primary Care Providers. Clinical Diabetes. 40(1):10\u201338","journal-title":"Clinical Diabetes."},{"issue":"8","key":"9659_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH et al (2020) Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 5(8):739\u2013752 (PubMed PMID: 32413340)","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"1","key":"9659_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s43856-023-00353-2","volume":"3","author":"F \u00c5berg","year":"2023","unstructured":"\u00c5berg F, F\u00e4rkkil\u00e4 M, Salomaa V et al (2023) Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use. Communications Medicine. 3(1):119","journal-title":"Communications Medicine."},{"issue":"9","key":"9659_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/liv.12226","volume":"33","author":"S Verma","year":"2013","unstructured":"Verma S, Jensen D, Hart J, Mohanty SR (2013) Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver International. 33(9):1398\u20131405","journal-title":"Liver International."},{"key":"9659_CR34","doi-asserted-by":"crossref","unstructured":"Ploug T, Holm S (2020) The four dimensions of contestable AI diagnostics - A patient-centric approach to explainable AI. Artificial Intelligence in Medicine. 107","DOI":"10.1016\/j.artmed.2020.101901"},{"key":"9659_CR35","doi-asserted-by":"publisher","unstructured":"Eskridge W, Cryer DR, Schattenberg JM, et al. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: The patient and physician perspective. J Clin Med. 2023;12(19).  https:\/\/doi.org\/10.3390\/jcm12196216.","DOI":"10.3390\/jcm12196216"},{"key":"9659_CR36","doi-asserted-by":"crossref","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367\u2013378 e365; quiz e314\u2013365","DOI":"10.1053\/j.gastro.2015.04.005"},{"issue":"8","key":"9659_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.37765\/ajmc.2023.89406","volume":"29","author":"AL Cipriani","year":"2023","unstructured":"Cipriani AL, Petz CA, Nielsen EM, Marsden J, Schreiner AD (2023) Statin prescribing patterns in patient-centered medical home patients with NAFLD. Am J Manag Care. 29(8):408\u2013413 (PubMed PMID: 37616147; PMCID: PMC10507683)","journal-title":"Am J Manag Care."},{"key":"9659_CR38","unstructured":"4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024. Diabetes care. 2024;47(Suppl 1):S52-s76; PubMed PMID: 38078591; PMCID: PMC10725809."},{"key":"9659_CR39","doi-asserted-by":"publisher","unstructured":"Le MH, Yeo YH, Li X, et al. 2019 Global NAFLD prevalence: A systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","DOI":"10.1016\/j.cgh.2021.12.002"},{"issue":"8","key":"9659_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao Y-Y, Zheng M-H (2024) Current status and future trends of the global burden of MASLD. Trends in Endocrinology & Metabolism. 35(8):697\u2013707","journal-title":"Trends in Endocrinology & Metabolism."},{"issue":"9","key":"9659_CR41","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2337\/dc22-0242","volume":"45","author":"M Fang","year":"2022","unstructured":"Fang M, Wang D, Coresh J, Selvin E (2022) Undiagnosed Diabetes in U.S. Adults: Prevalence and Trends. Diabetes care. 45(9):1994\u20132002 (PubMed PMID: 35817030; PMCID: PMC9472490)","journal-title":"Diabetes care."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09659-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:07:31Z","timestamp":1783382851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09659-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9659"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09659-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"All authors report no conflicts of interest with this work. Dr. Schreiner has previously consulted for Novo Nordisk and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This study (Pro00056541) involves human participants and was approved by the Institutional  Review Board at the Medical University of South Carolina (MUSC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval:"}},{"value":"The de-identified data that support the findings of this study are available on request from the corresponding author, Dr. Schreiner. The data are not publicly available due to their containing information that could compromise the privacy of research participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Statement:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}